Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
OpenClinica
Best for
Academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
What to consider
OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.
Clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems
What to consider
WeGuide brings participant-data collection and ongoing engagement into one study program for clinical trials and research studies. Teams can run screening, consent, forms, ePRO, reminders and follow-up in a branded participant app. The Integration Engine connects existing research systems when required. If the protocol needs intensive site-entered clinical data, complex queries, medical coding or advanced database management, use an appropriate EDC alongside the participant workflow. Suitability depends on those requirements, rather than study size or phase alone.
Less suitable for
Protocols requiring extensive in-visit eCRFs, complex data queries, medical coding, source-data verification or an enterprise database-lock workflow.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
OpenClinica vs WeGuide (EDC): category feature evidence and sources. Products are not ranked.
Category feature
OpenClinica
WeGuide
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
OpenClinica
Supported
OpenClinica says its technology has powered over 15,000 studies and more than three million patients.
Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.
Self-build and managed build are stated; amendment deployment is not documented.
WeGuide
Supported
Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.
Trial standards and ISO/SOC claims are stated; public certificate or report access is not established.
WeGuide
Supported
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
eConsent, eCOA and randomization establish base support despite the stated absence of native supply and coding.
WeGuide
Supported
Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.